Scale Biosciences (Scale Bio), a pacesetter in progressive and scalable single cell evaluation options, immediately introduced that the Chan Zuckerberg Initiative (CZI) has joined as a accomplice within the groundbreaking ‘ CZI will absolutely subsidize assist for 50 million cells’ price of awarded tasks. This partnership comes on the heels of an amazing response to the problem, with researchers pledging to research over 100 million cells inside days of the preliminary announcement.
The ‘100 Million Cell Problem,’ launched final month, goals to push the boundaries of single cell genomics analysis by encouraging large-scale tasks throughout various organic programs. With the assist of CZI and different program collaborators, Ultima Genomics and NVIDIA, the initiative is poised to make a good higher impression on the scientific neighborhood, serving to to extend our understanding of complicated organic programs and catalyze new discoveries, from primary analysis to translational drugs.
“Scale Bio’s visionary ‘100 Million Cell Problem’ aligns with our efforts to assist the one cell analysis neighborhood and create foundational assets that speed up science,” stated Jonah Cool, Cell Science Senior Program Officer on the Chan Zuckerberg Initiative. “We’re excited to assist scientists to take part on this groundbreaking problem and to make this analysis publicly out there on , a device we constructed that enables researchers to discover and draw new insights from mobile information.” CZI may even use this information to contribute to a data base for constructing to assist scientists discover the molecular underpinnings of human well being and illness.
Giovanna Prout, CEO of Scale Bio, expressed her enthusiasm for the partnership: “CZI’s dedication to this problem not solely validates the significance of large-scale single cell research, it additionally considerably expands the scope of what researchers can obtain. By way of the 100 million cell problem, Scale Bio and our collaborators hope to catalyze discoveries that would reshape precision drugs and our understanding of complicated organic programs.”
The scientific neighborhood has responded with overwhelming curiosity, submitting 40 tasks spanning a large spectrum of analysis disciplines. The submitted tasks display the breadth and depth of potential functions for large-scale single cell evaluation. Researchers have proposed research starting from creating complete atlases of assorted organ programs to investigating mobile heterogeneity in illness states and exploring cross-species comparisons in regenerative processes.
The ‘100 Million Cell Problem’ is enabled by Scale Bio’s new QuantumScale know-how, a single cell RNA sequencing resolution able to processing as much as 2 million cells per run. This new workflow was designed to empower researchers to pursue formidable, large-scale single cell omics tasks by providing unparalleled library preparation effectivity, high notch information high quality, and low prices.
The problem is continuous to till October 15, 2024, at midnight PDT. Initiatives proposing to research 1 million cells or extra are eligible for consideration. Chosen tasks might be introduced on the American Society of Human Genetics (ASHG) Annual Assembly in November 2024.
To supply extra details about the ‘100 Million Cell Problem,’ Scale Bio will host a stay net broadcast that includes representatives from collaborating companions. This occasion will supply researchers a chance to study extra in regards to the problem, the appliance course of and the way tasks might be chosen. To register for the stay net broadcast at 11:30 am PDT on September 24, 2024, please go to .
For extra details about the ‘100 Million Cell Problem’ and to submit a proposal, go to .
